Cellular immune activation reflects antiviral immunity and is a favorable prognostic marker in patients with cytomegalovirus infection

Transplant Proc. 1993 Feb;25(1 Pt 2):1419-20.

Authors

A P van den Berg¹, W J van Son, A M Tegzess, T H The

Affiliation

¹ Department of Clinical Immunology, University Hospital, Groningen, The Netherlands.

PMID: 7680157

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antigens, CD / analysis
Antigens, CD / immunology
Antigens, Differentiation, T-Lymphocyte / analysis
Antigens, Differentiation, T-Lymphocyte / immunology
CD56 Antigen
CD8 Antigens / analysis
CD8 Antigens / immunology
Cytomegalovirus Infections / blood
Cytomegalovirus Infections / drug therapy
Cytomegalovirus Infections / immunology*
Ganciclovir / therapeutic use
Graft Rejection / immunology
Graft Rejection / therapy
HLA-DR Antigens / analysis
Humans
Immunity, Cellular
Immunoglobulin G / blood
Immunoglobulin M / blood
Immunophenotyping
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use
Kidney Transplantation / immunology*
Killer Cells, Natural / immunology
Lymphocyte Activation
Prognosis
T-Lymphocyte Subsets / immunology*

Substances

Antigens, CD
Antigens, Differentiation, T-Lymphocyte
CD56 Antigen
CD8 Antigens
HLA-DR Antigens
Immunoglobulin G
Immunoglobulin M
Immunosuppressive Agents
Ganciclovir